Boc-L-Glutamic Acidum CAS 2419-94-5 (Boc-Glu-OH) Puritas >98.0% (HPLC) Factory
Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica acidi Boc-L-Glutamici (Boc-Glu-OH) (CAS: 2419-94-5) magna qualitate.Ruifu chemical seriem amino acidarum et derivatorum supplet.Praebere possumus terrarum traditionem, parvas et parvas quantitates in promptu.Purchase Boc-Glu-OH.Please contact: alvin@ruifuchem.com
Nomen chemicum | Boc-L-Glutamic Acid |
Synonyma | Boc-Glu-OH;Boc-L-Glu-OH;N-Boc-L-Glutamic Acidum;N-(tert-Butoxycarbonyl) L-Glutamic acid |
Stock Status | In Stock, Productio Capacity 30 Tons per Month |
CAS Number | 2419-94-5 |
Formulae hypotheticae | C10H17NO6 |
M. Pondus | 247.25 g/mol |
Liquescens punctum | 112.0~ 114.0℃ |
Density | 1.264 |
Aqua Solubility | Solutum in aqua |
Repono Nativ. | Frigus & siccum (0~8℃) |
COA & MSDS | Praesto |
Categoria | Boc-Amino Acids |
Brand | Ruifu Chemical |
Items | Signa inspectionis | Proventus |
Aspectus | Alba pulveris | Alba pulveris |
Liquescens punctum | 112.0~ 114.0℃ | 112.0~ 114.0℃ |
Imprimis rotationis [α]20/D | -16.5° ad -12.5° (C = I in MeOH) | -13.7° |
Damnum in Siccatio | <0.50% | 0.26% |
Puritas / Analysis Methodus | >98.0% (HPLC) | 98.5% |
TLC Analysis | One Macula | Obsequitur |
IR | Secundum Latin | Obsequitur |
Massa Imaginis | Secundum Latin | Obsequitur |
NMR Imaginum | Secundum Latin | Obsequitur |
conclusio | This Product by Inspection Accords with the Enterprise Standard | |
Usus principalis | Boc-Amino Acids;Peptide Synthesis;Pharmaceutical intermedia |
sarcina: Fluorinated Utrem, aluminium ffoyle, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Condite in vasis obsignatis apud frigus, siccum (0~8℃) horreum ab substantiis incompossibilibus.A luce et humore protege.
Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Annorum Usus?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Periculosam symbola Xn - Noxia
Periculum Codes
R20/21/22 - Inspiratio noxia, in contactu cum cute et absorpta.
R36/37/38 - Irritando ad oculos, systema respiratorium et cutem.
Salus Descriptio
S22 — Pulverem ne respirare.
S24/25 - contactus cum cute et oculis fuge.
S36 - gere idoneos tutelae vestis.
S26 - In contactu cum oculis, statim cum aqua multa ablue et consilium medicinae quaeras.
WGK Germania 3
HS CIC 2922491990
Boc-L-Glutamicum Acidum (Boc-Glu-OH) (CAS: 2419-94-5) forma N-Boc servata est forma Acidi Glutamici L-Glutamici.Acidum L-glutamicum est acidum amino non essentiale quod refert ad systema nervosum mammalium centrale.Amino acida et derivata, synthesis peptidis, synthesis organica media, intermedia pharmaceutica, reagentia diametica.Boc-Glu-OH adhiberi potest intermedium pharmaceuticum ex Lenalidomide.Mense Decembri 2005, Cibus US et Administration medicamentis (FDA) probatus lenalidomide utendum est in tractatione syndrome myelodysplasticae (MDS).